Common inflammation pathway turns anthrax toxin into killer

Bacillus anthracis lethal toxin (LT) is a determinant of lethal anthrax. Its function in myeloid cells is required for bacterial dissemination, and LT itself can directly trigger dysfunction of the cardiovascular system.

DarioHealth acquires Twill, hoping it’s a shortcut to profitability

DarioHealth, which makes apps for managing chronic diseases, today announced it will acquire digital mental health company Twill for $10 million in cash plus stock

February 21, 2024

PacBio enables rare and inherited disease research by adding tertiary analysis partners to PacBio Compatible

Partnerships maximize value of HiFi data and complete the full end-to-end workflow for PacBio customers.

November 1, 2023

FDA grants full approval to Travere’s Filspari for IgAN

Travere Therapeutics won full approval for Filspari, which treats a rare autoimmune disease that affects the kidneys. Filspari, also known as sparsentan, received an accelerated

September 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.